Influenza News and Research

Latest Influenza News and Research

Nasal delivery of single-domain antibodies improves SARS-CoV-2 symptoms in animal model

In a recent study published in the journal PLOS Pathogens, scientists showed that nasal administration of a single-domain antibody (VHH), named K-874A, brought about inhibition of SARS-CoV-2 titers in infected lungs of Syrian hamsters.

19 Oct 2021

Factors contributing to a weak antibody response to the Pfizer COVID-19 vaccine

A new study discusses risk factors for the failure of seroconversion following full vaccination with the COVID-19 Pfizer vaccine.

18 Oct 2021

Surveillance, prevention of COVID-19 and seasonal influenza in Europe

In the northern hemisphere, annual seasonal influenza activity usually causes a high burden of disease during the winter months.

18 Oct 2021

New risk measure can better predict pandemic spread than other models

COVID-19 is not the flu. The disease caused by the novel SARS-CoV-2 virus is more transmissible, and deadlier, than most influenza epidemics we've encountered in our lifetimes, and scientists and physicians are still learning new things about the disease and its long-term effects.

15 Oct 2021

Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine

The results of a phase 2 clinical trial featuring a SARS-CoV-2 recombinant protein vaccine developed by GlaxoSmithKline are reported, demonstrating a favorable immune response amongst both naïve and non-naïve adults with an acceptable safety profile.

15 Oct 2021

NIH RADx initiative announces $77.7 million to develop new rapid COVID-19 diagnostic tests

The NIH Rapid Acceleration of Diagnostics (RADx) initiative announced today that it has issued contract awards totaling $77.7 million to develop and manufacture 12 new rapid diagnostic tests for SARS-CoV-2, the virus that causes COVID-19.

15 Oct 2021

Scientists testify the importance of timely influenza vaccination

With flu season approaching in the United States, new research from an international team of scientists testifies to the importance of timely vaccination

15 Oct 2021

Cell-based quadrivalent influenza vaccine produces sufficient immune response in children

A cell-based influenza vaccine has effectively provided protection against the flu in children and adolescents, according to a new study.

15 Oct 2021

SARS-CoV-2 induces tissue immune memory

A new study reports that the SARS-CoV-2 induces protective tissue memory that includes both humoral and cellular elements to protect specific tissue sites.

14 Oct 2021

Improving COVID-19 vaccinations through contact-tracing apps

In our latest interview, News-Medical spoke to Dr. Mark Penney about how we can improve COVID-19 vaccinations through contact-tracing apps.

14 Oct 2021

Methods used to limit transmission of SARS-CoV-2 effective against other viruses in China

Researchers from Shenzhen's Children's Hospital have been investigating the occurrence of these diseases while these measures were in effect to understand better how to curb their transmission.

14 Oct 2021

Poor timing of flu vaccinations associated with poor birth outcomes and cesarean births

With flu season approaching in the United States, new research from an international team of scientists testifies to the importance of timely vaccination: Poor timing of influenza vaccination campaigns in the semi-arid region of Brazil led to an increase in premature births, lower birth-weight babies and the need to deliver more babies by cesarean section, the researchers found.

13 Oct 2021

Scientists develop an extremely potent siRNA with broad activity against SARS-CoVs

Researchers in Germany have developed a promising approach to suppressing the viral replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

12 Oct 2021

Vaccinated children induced significantly higher antibody titers than naturally SARS-CoV-2 infected children

A recent preprint discusses the antibody response to the nucleic acid vaccines against SARS-CoV-2 when administered to children aged 7-11 years.

12 Oct 2021

New compound can prevent SARS-CoV-2 and related coronaviruses from entering cells

Scientists at Washington University School of Medicine in St. Louis have developed a compound that prevents SARS-CoV-2 and related coronaviruses from entering cells.

11 Oct 2021

COVID-19 aerosol transmission simulation-based risk analysis for in-person learning

Researchers develop a simulation model to characterize the risks and uncertainties associated with infections from aerosol exposure during in-person classes.

11 Oct 2021

Prior immunity to influenza, not SARS-CoV-2, prevents severe disease and mortality

Researchers from the Israel Institute of Biological Research delineated the interplay between IAV and SARS CoV-2 infections.

11 Oct 2021

Administering flu vaccines to children having surgery substantially boosts vaccination rates

Actively offering an influenza (flu) vaccination to children having surgery and general anesthesia increased the number of patients vaccinated by 3,500% at Children's Hospital Colorado, Aurora, according to a study presented at the ANESTHESIOLOGY® 2021 annual meeting.

11 Oct 2021

COVID-19 vaccination rates among minority populations

A new study discusses offers insights into how minority groups can be effectively persuaded to take the currently available COVID-19 vaccines.

10 Oct 2021

Lipids, COVID-19, and host immunity

A new study from a team of researchers at the University of Pennsylvania examines the role played by lipids in this disease.

10 Oct 2021

Influenza News and Research

Latest Influenza News and Research

Nasal delivery of single-domain antibodies improves SARS-CoV-2 symptoms in animal model

Factors contributing to a weak antibody response to the Pfizer COVID-19 vaccine

Surveillance, prevention of COVID-19 and seasonal influenza in Europe

New risk measure can better predict pandemic spread than other models

Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine

NIH RADx initiative announces $77.7 million to develop new rapid COVID-19 diagnostic tests

Scientists testify the importance of timely influenza vaccination

Cell-based quadrivalent influenza vaccine produces sufficient immune response in children

SARS-CoV-2 induces tissue immune memory

Improving COVID-19 vaccinations through contact-tracing apps

Methods used to limit transmission of SARS-CoV-2 effective against other viruses in China

Poor timing of flu vaccinations associated with poor birth outcomes and cesarean births

Scientists develop an extremely potent siRNA with broad activity against SARS-CoVs

Vaccinated children induced significantly higher antibody titers than naturally SARS-CoV-2 infected children

New compound can prevent SARS-CoV-2 and related coronaviruses from entering cells

COVID-19 aerosol transmission simulation-based risk analysis for in-person learning

Prior immunity to influenza, not SARS-CoV-2, prevents severe disease and mortality

Administering flu vaccines to children having surgery substantially boosts vaccination rates

COVID-19 vaccination rates among minority populations

Lipids, COVID-19, and host immunity

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Influenza News and Research

Latest Influenza News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in